Arkolith/Insider Trading/FMDT/Form 4

Moretti August J

Chief Financial Officer4D Molecular Therapeutics, Inc. (FMDT) · full profile →Form 4 · filed May 16, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2023Option exercise(M)3K$9.41$28K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2023Option exercise(M)3K—$0217K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000044) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML